Duration of benefit in patients with autoimmune PAP after inhaled GM-CSF therapy

	문성우		2
	Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled GM CSF therapy.pdf		42
2013년 11월 28일 journal club   Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled GM-CSF therapy   R1 김대훈
	2013-12월 VATS conference
	Lung cancer update guideline